Generated: December 17, 2017
DrugPatentWatch Database Preview
Details for Patent: 3,800,481
« Back to Dashboard
Summary for Patent: 3,800,481
|Title:|| HINGE TYPE UNITS PERMANENTLY MOUNTED IN A CYLINDRICAL HUB STRUCTURE WITH REPLACEABLE FINISHING PACKS PROVIDED FOR THE UNITS|
|Abstract:||The rotary flap or finishing wheel or tool has a plurality of radially extending finishing units or packs mounted in a circumferential series on a hub structure. The finishing units are mounted on the body structure by a dual clip-type assembly including an inner axially elongated and rigid clip member forming the primary component of the pack and an axially elongated outer clip member supporting or carrying the finishing or fill material and forming the secondary components of the finishing unit. The mount of the inner clip member is afforded at an inner axially extending through-bore therein which encircles an axial pin component located adjacent the outer periphery of the hub structure. The inner clip member has an axially elongated, keyhole-type slot or groove that opens re-entrantly along the entire axial length of the outer free clip end. Replaceable units of fill or finishing material are each constituted in part by the secondary or outer clip component or member having radial arms which are coextensive in axial length with the finishing material and are stapled in place within the latter. The arms integrally connect with one another at a radially inner bight at which, along with a telescoped inner wear sleeve, the pre-assembled finishing unit-secondary clip member -- is telescoped into the re-entrant keyhole recess of the primary clip member. Either one or both of the clip members of each finishing unit are mounted for pivotal movement.|
|Inventor(s):|| Belanger; James A. (Livonia, MI) |
|Assignee:|| Belanger, Inc. (Northville, MI) |
Patent Claim Types:|
see list of patent claims
No matches for this query
International Patent Family for Patent: 3,800,481
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws,
it is advisable to have patent counsel verify freedom to operate.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.